J. G. Coen van Hasselt

ORCID: 0000-0002-1664-7314
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotics Pharmacokinetics and Efficacy
  • Drug Transport and Resistance Mechanisms
  • Antibiotic Resistance in Bacteria
  • Computational Drug Discovery Methods
  • Pneumonia and Respiratory Infections
  • Statistical Methods in Clinical Trials
  • Cannabis and Cannabinoid Research
  • Pharmacogenetics and Drug Metabolism
  • Epilepsy research and treatment
  • Evolution and Genetic Dynamics
  • Psychedelics and Drug Studies
  • Antimicrobial Resistance in Staphylococcus
  • Cancer Treatment and Pharmacology
  • Bioinformatics and Genomic Networks
  • Pharmacological Effects and Toxicity Studies
  • Tuberculosis Research and Epidemiology
  • Cancer Genomics and Diagnostics
  • Gene Regulatory Network Analysis
  • Forensic Toxicology and Drug Analysis
  • Metabolomics and Mass Spectrometry Studies
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Sepsis Diagnosis and Treatment
  • Immune Response and Inflammation
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life

Centre for Human Drug Research
2016-2025

Leiden University
2016-2025

Icahn School of Medicine at Mount Sinai
2016-2021

The Netherlands Cancer Institute
2011-2019

Center for Systems Biology
2018

Pharmac
2018

Oncode Institute
2011-2016

Slotervaartziekenhuis
2011-2015

Dutch Cancer Society
2013

GlaxoSmithKline (Netherlands)
2013

This article represents the first in a series of tutorials on model evaluation nonlinear mixed effect models (NLMEMs), from International Society Pharmacometrics (ISoP) Model Evaluation Group. Numerous tools are available for NLMEM, with particular emphasis visual assessment. basic tutorial focuses presenting graphical NLMEM continuous data. It illustrates graphs correct or misspecified models, discusses their pros and cons, recalls definition metrics used.

10.1002/psp4.12161 article EN cc-by-nc-nd CPT Pharmacometrics & Systems Pharmacology 2016-11-24

While it is known that endocannabinoids (eCB) modulate multiple neuronal functions, the molecular mechanism governing their release and transport remains elusive. Here, we propose an "on-demand release" model, wherein formation of microvesicles, a specific group extracellular vesicles (EVs) containing eCB, 2-arachidonoylglycerol (2-AG), important step. A coculture model system combines reporter cell line expressing fluorescent eCB sensor, G protein-coupled receptor-based (GRAB)eCB2.0, cells...

10.1073/pnas.2421717122 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2025-02-20
Kathryn Thomson Calie Dyer Feiyan Liu Kirsty Sands Edward Portal and 95 more Maria J. Carvalho M. Barrell Ian Boostrom Susanna Dunachie Refath Farzana Ana Ferreira Francis Frayne Brekhna Hassan Ellis L. Jones Lim Jones Jordan Mathias Rebecca Milton Jessica Rees Grace J. Chan Delayehu Bekele Mahlet Abayneh Sulagna Basu Ranjan K. Nandy Bijan Saha Kenneth Iregbu Fatima Modibbo Stella Uwaezuoke Rabaab Zahra Haider Shirazi Najeeb U Syed Jean-Baptiste Mazarati Aniceth Rucogoza Lucie Gaju Shaheen Mehtar Andre Nyandwe Hamama Bulabula Andrew Whitelaw J. G. Coen van Hasselt Timothy R. Walsh Samir K. Saha Mohammad Shahidul Islam Zabed Bin-Ahmed Wazir Ahmed Taslima Begum Mitu Chowdhury Shaila Sharmin Chumki Rani Dey Uttam Mohammad Abdul Matin Sowmitra Ranjan Chakraborty Sadia Tasmin Dipa Rema Rashida Khatun Liza Nath Nigatu Balkachew Delayehu Bekele Katherine Cl Schaughency Semaria Solomon Zenebe Gebreyohanes Rozina Ambachew Oludare A. Odumade Misgana Haileselassie Grace J. Chan Abigail A. Russo Redeat Workneh Gesit Metaferia Mahlet Abayneh Yahya Mohammed Tefera Biteye Alula M. Teklu Wendimagegn Gezahegn Partha Sarathi Chakravorty Anuradha Mukherjee Ranjan K. Nandy Samarpan Roy Anuradha Sinha Sharmi Naha Sukla Saha Malakar Siddhartha Bose Monaki Majhi Subhasree Sahoo Putul Mukherjee Sumitra Kumari Routa Chaitali Nandi Sulagna Basu Bijan Saha Pinaki Chattopadhyay Fatima Z Modibbo Stella Uwaezuoke Dilichukwu Meduekwe Khairiyya Muhammad Queen Nsude Ifeoma Ukeh Mary-Joe Okenu Chinenye Akpulu Samuel Yakubu Vivian Asunugwo Folake Aina Isibong Issy Dolapo Adekeye Adiele Eunice

Sepsis is a major contributor to neonatal mortality, particularly in low-income and middle-income countries (LMICs). WHO advocates ampicillin-gentamicin as first-line therapy for the management of sepsis. In BARNARDS observational cohort study sepsis antimicrobial resistance LMICs, common pathogens were characterised via whole genome sequencing (WGS) profiles. this substudy BARNARDS, we aimed assess use efficacy empirical antibiotic therapies commonly used LMICs

10.1016/s1473-3099(21)00050-5 article EN cc-by The Lancet Infectious Diseases 2021-08-09

In the POET (Partial Oral Endocarditis Treatment) trial, oral step-down therapy was noninferior to full-length intravenous antibiotic administration. The aim of present study perform pharmacokinetic/pharmacodynamic analyses for treatments infective endocarditis assess probabilities target attainment (PTAs).Plasma concentrations antibiotics were measured at day 1 and 5. Minimal inhibitory (MICs) determined bacteria causing (streptococci, staphylococci, or enterococci)....

10.1093/cid/ciad168 article EN Clinical Infectious Diseases 2023-03-22

Abstract The evolution of antimicrobial resistance (AMR) in biofilms has been repeatedly studied by experimental vitro, but rarely vivo. complex microenvironment at the infection site imposes selective pressures on bacterial biofilms, potentially influencing development AMR. We report here AMR an vivo mouse model Pseudomonas aeruginosa biofilm lung infection. P. embedded seaweed alginate beads underwent four successive passages with or without ciprofloxacin (CIP) exposure. CIP was assessed...

10.1093/ismejo/wrae036 article EN cc-by The ISME Journal 2024-01-01

3,4-Diaminopyridine and pyridostigmine are widely used to treat Lambert–Eaton myasthenic syndrome (LEMS), either alone or in combination. enhances the release of acetylcholine at neuromuscular synapse, inhibits degradation this neurotransmitter. Although could lead a synergistic effect on transmission, no studies have compared effects these drugs patients with LEMS. Therefore, we performed placebo-controlled, double-dummy, double-blind, randomized, crossover study nine Clinical Pharmacology...

10.1038/clpt.2009.35 article EN Clinical Pharmacology & Therapeutics 2009-04-08

Drug development targeting the central nervous system (CNS) is challenging due to poor predictability of drug concentrations in various CNS compartments. We developed a generic physiologically based pharmacokinetic (PBPK) model for prediction relevant System-specific and drug-specific parameters were derived from literature silico predictions. The was validated using detailed concentration-time profiles 10 drugs rat plasma, brain extracellular fluid, 2 cerebrospinal fluid sites, total...

10.1002/psp4.12250 article EN cc-by-nc-nd CPT Pharmacometrics & Systems Pharmacology 2017-09-11

Creating a cDNA library for deep mRNA sequencing (mRNAseq) is generally done by random priming, creating multiple fragments along each transcript. A 3'-end-focused approach cannot detect differential splicing, but has potentially higher throughput at lower cost, with the ability to improve quantification using transcript molecule counting unique molecular identifiers (UMI) that correct PCR bias. Here, we compare an implementation of such 3'-digital gene expression (3'-DGE) "conventional"...

10.1038/s41598-017-14892-x article EN cc-by Scientific Reports 2017-11-01

Predicting target site drug concentration in the brain is of key importance for successful development drugs acting on central nervous system. We propose a generic mathematical model to describe pharmacokinetics compartments, and apply this predict human disposition. A consisting several physiological compartments rat was developed using rich concentration-time profiles from nine structurally diverse plasma, extracellular fluid, two cerebrospinal fluid compartments. The effect active...

10.1007/s11095-016-2065-3 article EN cc-by Pharmaceutical Research 2016-11-18

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Cannabis based medicines are registered as a treatment for various indications, such pain and spasms in multiple sclerosis (MS) patients, anorexia nausea patients with HIV or receiving cancer treatment. the pharmacokinetics of administration routes cannabis variable dosing is hard to regulate. STUDY ADDS Namisol new tablet containing pure THC (>98%) that has beneficial pharmacokinetic profile after oral administration. gives quick onset...

10.1111/j.1365-2125.2012.04164.x article EN British Journal of Clinical Pharmacology 2012-06-11

ABSTRACT The present study determined the pharmacokinetic profile of vancomycin in premature Malaysian infants. A one-compartment infusion model with first-order elimination was fitted to serum concentration data ( n = 835 points) obtained retrospectively from drug monitoring records 116 newborn Vancomycin concentrations were estimated by a fluorescence polarization immunoassay. Population and individual estimates clearance distribution volume factors which affected variability observed for...

10.1128/aac.01370-09 article EN Antimicrobial Agents and Chemotherapy 2010-04-13

Abstract Aims The enzymatic activity of dihydropyrimidine dehydrogenase (DPD) and thymidylate synthase (TS) are important for the tolerability efficacy fluoropyrimidine drugs. In present study, we explored between‐subject variability (BSV) circadian rhythmicity in DPD TS human volunteers. Methods BSVs ( n = 20) peripheral blood mononuclear cells (PBMCs) plasma, measured by means dihydrouracil (DHU) uracil (U) plasma levels DHU : U ratio 40), PBMCs 19), were examined. Samples collected every...

10.1111/bcp.13007 article EN British Journal of Clinical Pharmacology 2016-05-10

Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one leads a second antibiotic, may have the potential limit emergence of antimicrobial resistance. However, it remains unclear how best design CS-based treatment schedules. To address this problem, we use mathematical modelling study effects pathogen- and drug-specific characteristics for different designs on bacterial population dynamics evolution. We confirm that simultaneous one-day cycling treatments...

10.1038/s41467-021-25927-3 article EN cc-by Nature Communications 2021-09-28
Coming Soon ...